Year
2023
-
Xortx Gets Orphan Drug Nod for Polycystic Kidney Disease
-
Eli Lilly to sell low blood sugar drug to Amphastar
-
Avidity Biosciences Inc. Granted FDA Fast Track Designation for Antibody AOC 1044
-
AstraZeneca and Ionis’ ATTRv-PN therapy meets trial endpoints
-
Trefoil Therapeutics reports new findings from FECD therapy trial
-
IN8bio’s INB-400, INB-410 GMB Treatments Designated Orphan Drug by FDA
-
Janssen Gets EU Approval for Prostate Cancer Drug Akeega
-
The EU outlined its plan to equalize drug access and lower prices. Pharma firms are not happy
-
Sun Pharma pauses US drug exports from India plant after FDA scolding
-
Eli Lilly raises annual profit forecast on strength of diabetes drug